What are the clinical implications of these findings, and how should this information be considered in patient management decisions?
First, clinicians should consider the likelihood of PE in a structured manner based on patients' presenting histories and physical examinations much the way Anderson and colleagues did, and based on those assessments,
proceed, as necessary, to D-dimer testing. These 2 steps may substantially reduce the probability that PE, at least large clots, are present18 and obviate the need for additional study.
Where significant concern remains, including some patients whose PE probability may not be very high but whose comorbidities put them at great risk were an embolism to occur, additional testing should be pursued. If readily available, lower extremity ultrasound studies to search for deep vein thrombosis to treat those patients found to have such clots is a reasonable next step. If deep vein thromboses are excluded or if ultrasound is not immediately available, then imaging of the chest is indicated. At the current state-of-the-art CTPA, using multidetector scanners, appears to be an excellent imaging choice unless there is a contraindication to dye administration or, perhaps,
in pregnancy because of the higher dose of radiation with CTPA. For patients who cannot be studied by multidetector-row CTPA, /
scanning would still be available. Of note, there is no evidence from the study by Anderson et al1 that single-detector scans are superior to / scan.